This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
AB-1966 Gene Synthesis Providers. Edn. 2019–2020 Regular Session https://leginfo.legislature.ca.gov/faces/billTextClient.xhtml?bill_id=201920200AB1966 (2020).
US National Academies of Sciences, Engineering and Medicine. Biodefense in the Age of Synthetic Biology (National Academies Press, 2018).
Department of Health and Human Services. Fed. Regist. 75, 62820–62832 (2010).
Carter, S. R. & Friedman, R. M. DNA Synthesis and Biosecurity: Lessons Learned and Options for the Future (J. Craig Venter Institute, 2015).
Kobokovich, A., West, R., Montague, M., Inglesby, T. & Gronvall, G. K. Health Secur. 17, 419–429 (2019).
Bergin, J. Synthetic Biology: Global Markets https://www.bccresearch.com/market-research/biotechnology/synthetic-biology-global-markets.html (BCC Research, 2018).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Rights and permissions
About this article
Cite this article
West, R., Gronvall, G.K. California shows the way for biosecurity in commercial gene synthesis. Nat Biotechnol 38, 1021 (2020). https://doi.org/10.1038/s41587-020-0667-0
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41587-020-0667-0